Quest Diagnostics (DGX) Gross Margin (2009 - 2026)

Quest Diagnostics has disclosed Gross Margin across 18 years of filings, most recently posting 32.54% for Q1 2026.

• Gross Margin for Q1 2026 came in at 32.54%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 33.2% (up 36.0% YoY), and the FY2025 annual result was 33.21%, up 35.0% from the prior year.
• Gross Margin came in at 32.54% for Q1 2026 at Quest Diagnostics, roughly flat from 32.43% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 36.96% in Q1 2022 to a low of 32.17% in Q4 2023.
• The 5-year median for Gross Margin is 32.85% (2023), against an average of 33.38%.
• Across the five-year window, Gross Margin sank 490 bps in 2022 and soared 110 bps in 2025, its largest moves.
• Quest Diagnostics' Gross Margin stood at 32.49% in 2022, then dropped by 1 bps to 32.17% in 2023, then increased by 2 bps to 32.74% in 2024, then decreased by 1 bps to 32.43% in 2025, then gained by 0 bps to 32.54% in 2026.
• The last three Gross Margin figures came in at 32.54% (Q1 2026), 32.43% (Q4 2025), and 33.7% (Q3 2025), per Business Quant data.